Literature DB >> 33521908

The PrEP Journey: Understanding How Internal Drivers and External Circumstances Impact The PrEP Trajectory of Adolescent Girls and Young Women in Cape Town, South Africa.

Shannon O'Rourke1, Miriam Hartmann1, Laura Myers2, Nosiphiwo Lawrence2, Katherine Gill2, Jennifer F Morton3, Connie L Celum3, Linda-Gail Bekker2, Ariane van der Straten4,5,6.   

Abstract

Despite high risk for HIV, South African adolescent girls and young women (AGYW) experience numerous challenges with adherence to PrEP. To better understand AGYW's motivations for PrEP and factors that impact PrEP adherence, we conducted serial in-depth interviews with 22 South African AGYW during a 12 month prospective study. Interviews explored motivations and initial experiences of PrEP use, patterns of adherence, social support, and reasons for stopping or persisting with PrEP. We also assessed drug levels as a biomarker of adherence; dried blood spots were collected at months 1, 2, 3, 6, and 12 to assess intracellular tenofovir diphosphate levels. An end-user journey analytical approach revealed themes related to behavioral and emotional aspects of use, including multilevel factors leading to divergent PrEP adherence trajectories. Our findings highlight how internal versus external motivations drive PrEP use, as well as how positive identity formation and challenges are handled, which are essential to understand AGYW in their PrEP journeys.

Entities:  

Keywords:  Adolescent girls and young women; End-user journey; HIV prevention; Oral pre-exposure prophylaxis; South Africa

Mesh:

Substances:

Year:  2021        PMID: 33521908      PMCID: PMC8651257          DOI: 10.1007/s10461-020-03145-0

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  2 in total

Review 1.  HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.

Authors:  Connie L Celum; Sinead Delany-Moretlwe; Jared M Baeten; Ariane van der Straten; Sybil Hosek; Elizabeth A Bukusi; Margaret McConnell; Ruanne V Barnabas; Linda-Gail Bekker
Journal:  J Int AIDS Soc       Date:  2019-07       Impact factor: 5.396

2.  Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.

Authors:  Ariane van der Straten; Jonathan Stadler; Ellen Luecke; Nicole Laborde; Miriam Hartmann; Elizabeth T Montgomery
Journal:  J Int AIDS Soc       Date:  2014-09-08       Impact factor: 5.396

  2 in total
  8 in total

1.  PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.

Authors:  Connie L Celum; Elizabeth A Bukusi; Linda Gail Bekker; Sinead Delany-Moretlwe; Lara Kidoguchi; Victor Omollo; Elzette Rousseau; Danielle Travill; Jennifer F Morton; Felix Mogaka; Gabrielle O'Malley; Gena Barnabee; Ariane van der Straten; Deborah Donnell; Urvi M Parikh; Lauren Kudrick; Peter L Anderson; Jessica E Haberer; Linxuan Wu; Renee Heffron; Rachel Johnson; Susan Morrison; Jared M Baeten
Journal:  J Int AIDS Soc       Date:  2022-07       Impact factor: 6.707

2.  "These Girls Have a Chance to be the Future Generation of HIV Negative": Experiences of Implementing a PrEP Programme for Adolescent Girls and Young Women in South Africa.

Authors:  Zoe Duby; Brittany Bunce; Chantal Fowler; Kim Jonas; Kate Bergh; Darshini Govindasamy; Colleen Wagner; Catherine Mathews
Journal:  AIDS Behav       Date:  2022-07-06

3.  "You tell him that 'baby, I am protecting myself'": Women's agency and constraint around willingness to use pre-exposure prophylaxis in the Masibambane Study.

Authors:  Abigail Harrison; Nonhlonipho Bhengu; Lori Miller; Theresa Exner; Nonkululeko Tesfay; Slindile Magutshwa; Silindile Khumalo; Scarlett Bergam; Susie Hoffman; Jill Hanass-Hancock
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

4.  Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence.

Authors:  Danielle Giovenco; Katherine Gill; Lauren Fynn; Menna Duyver; Shannon O'Rourke; Ariane van der Straten; Jennifer F Morton; Connie L Celum; Linda-Gail Bekker
Journal:  PLoS One       Date:  2021-03-05       Impact factor: 3.752

5.  Adolescent girls and young women's PrEP-user journey during an implementation science study in South Africa and Kenya.

Authors:  Elzette Rousseau; Ariana W K Katz; Shannon O'Rourke; Linda-Gail Bekker; Sinead Delany-Moretlwe; Elizabeth Bukusi; Danielle Travill; Victor Omollo; Jennifer F Morton; Gabrielle O'Malley; Jessica E Haberer; Renee Heffron; Rachel Johnson; Connie Celum; Jared M Baeten; Ariane van der Straten
Journal:  PLoS One       Date:  2021-10-14       Impact factor: 3.752

Review 6.  Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations - Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine.

Authors:  E Rousseau; R F Julies; N Madubela; S Kassim
Journal:  Curr HIV/AIDS Rep       Date:  2021-10-27       Impact factor: 5.071

7.  Improving access to pre-exposure prophylaxis for adolescent girls and young women: recommendations from healthcare providers in eastern Zimbabwe.

Authors:  Morten Skovdal; Phyllis Magoge-Mandizvidza; Freedom Dzamatira; Rufurwokuda Maswera; Constance Nyamukapa; Ranjeeta Thomas; Owen Mugurungi; Simon Gregson
Journal:  BMC Infect Dis       Date:  2022-04-23       Impact factor: 3.667

8.  Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.

Authors:  Laura Nyblade; Jacqueline W Ndirangu; Ilene S Speizer; Felicia A Browne; Courtney Peasant Bonner; Alexandra Minnis; Tracy L Kline; Khatija Ahmed; Brittni N Howard; Erin N Cox; Abigail Rinderle; Wendee M Wechsberg
Journal:  BMC Public Health       Date:  2022-10-14       Impact factor: 4.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.